Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurice Beghetti

Showing results (151-160 of 246) with videos related to

Pageof 25
Sort By:
Hypertension (Dallas, Tex. : 1979)|March 10, 2010
Central venous hypoxemia is a determinant of human atrial ATP-sensitive potassium channel expression: evidence for a novel hypoxia-inducible factor 1alpha-Forkhead box class O signaling pathwayVéronique Raeis, Pierre Philip-Couderc, Angela Roatti, et al.
Respiratory Research|April 29, 2011
Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertensionWalid Habre, Gergely Albu, Tibor Z Janosi, et al.
Heart (British Cardiac Society)|July 3, 2015
Riociguat for pulmonary arterial hypertension associated with congenital heart diseaseStephan Rosenkranz, Hossein-Ardeschir Ghofrani, Maurice Beghetti, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2006
Long-term outcome after surgical intervention and interventional procedures for the management of Takayasu's arteritis in childrenAfksendiyos Kalangos, Jan T Christenson, Mustafa Cikirikcioglu, et al.
International Journal of Cardiology|July 31, 2007
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension studyMichael A Gatzoulis, Maurice Beghetti, Nazzareno Galiè, et al.
European Journal of Pediatrics|April 23, 2010
Reduced physical activity level and cardiorespiratory fitness in children with chronic diseasesAlbane B R Maggio, Michaël F Hofer, Xavier E Martin, et al.
International Journal of Cardiology|May 26, 2009
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysisRolf M F Berger, Maurice Beghetti, Nazzareno Galiè, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Hemodynamic and prognostic impact of the diastolic pulmonary arterial pressure in children with pulmonary arterial hypertension-a registry-based analysisChristian Apitz, Rolf M F Berger, D Dunbar Ivy, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 11, 2019
Congenital Portosystemic Shunts: Current Diagnosis and ManagementValérie A McLin, Stephanie Franchi Abella, Dominique Debray, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 2, 2006
Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: a potential new drug for rescue therapyAlessandro Motti, Cécile Tissot, Peter C Rimensberger, et al.
Pageof 25

Showing results (151-160 of 246) with videos related to

Sort By:
Pageof 25
Hypertension (Dallas, Tex. : 1979)|March 10, 2010
Central venous hypoxemia is a determinant of human atrial ATP-sensitive potassium channel expression: evidence for a novel hypoxia-inducible factor 1alpha-Forkhead box class O signaling pathwayVéronique Raeis, Pierre Philip-Couderc, Angela Roatti, et al.
Respiratory Research|April 29, 2011
Prevention of bronchial hyperreactivity in a rat model of precapillary pulmonary hypertensionWalid Habre, Gergely Albu, Tibor Z Janosi, et al.
Heart (British Cardiac Society)|July 3, 2015
Riociguat for pulmonary arterial hypertension associated with congenital heart diseaseStephan Rosenkranz, Hossein-Ardeschir Ghofrani, Maurice Beghetti, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2006
Long-term outcome after surgical intervention and interventional procedures for the management of Takayasu's arteritis in childrenAfksendiyos Kalangos, Jan T Christenson, Mustafa Cikirikcioglu, et al.
International Journal of Cardiology|July 31, 2007
Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension studyMichael A Gatzoulis, Maurice Beghetti, Nazzareno Galiè, et al.
European Journal of Pediatrics|April 23, 2010
Reduced physical activity level and cardiorespiratory fitness in children with chronic diseasesAlbane B R Maggio, Michaël F Hofer, Xavier E Martin, et al.
International Journal of Cardiology|May 26, 2009
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysisRolf M F Berger, Maurice Beghetti, Nazzareno Galiè, et al.
Cardiovascular Diagnosis and Therapy|September 16, 2021
Hemodynamic and prognostic impact of the diastolic pulmonary arterial pressure in children with pulmonary arterial hypertension-a registry-based analysisChristian Apitz, Rolf M F Berger, D Dunbar Ivy, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 11, 2019
Congenital Portosystemic Shunts: Current Diagnosis and ManagementValérie A McLin, Stephanie Franchi Abella, Dominique Debray, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 2, 2006
Intravenous adenosine for refractory pulmonary hypertension in a low-weight premature newborn: a potential new drug for rescue therapyAlessandro Motti, Cécile Tissot, Peter C Rimensberger, et al.
Pageof 25